These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 2080934)

  • 1. [Intranasal salmon calcitonin for the prophylaxis of bone mineral loss in steroid-treated chronic obstructive lung diseases ].
    Böhning W; Ringe JD; Welzel D; Bode V
    Arzneimittelforschung; 1990 Sep; 40(9):1000-3. PubMed ID: 2080934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salmon calcitonin in the therapy of corticoid-induced osteoporosis.
    Ringe JD; Welzel D
    Eur J Clin Pharmacol; 1987; 33(1):35-9. PubMed ID: 3319638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of intranasal salmon calcitonin therapy on bone mineral density in idiopathic male osteoporosis without vertebral fractures--an open label study.
    Tóth E; Csupor E; Mészáros S; Ferencz V; Németh L; McCloskey EV; Horváth C
    Bone; 2005 Jan; 36(1):47-51. PubMed ID: 15664001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of postmenopausal osteoporosis with salmon calcitonin nasal spray: evaluation by bone mineral content and biochemical patterns.
    Tolino A; Romano L; Ronsini S; Riccio S; Montemagno U
    Int J Clin Pharmacol Ther Toxicol; 1993 Jul; 31(7):358-60. PubMed ID: 8370634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical efficacy of treatment with salmon calcitonin, administered intranasally for 1 year, in stabilized postmenopausal osteoporosis].
    Agnusdei D; Gonnelli S; Camporeale A; Batignani T; Nardi P; Ianes A; Gennari C
    Minerva Endocrinol; 1989; 14(3):169-76. PubMed ID: 2695815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient responsiveness to calcitonin salmon nasal spray: a subanalysis of a 2-year study.
    Overgaard K; Lindsay R; Christiansen C
    Clin Ther; 1995; 17(4):680-5. PubMed ID: 8565031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Use of salmon calcitonin nasal spray in the prevention of corticosteroid-induced osteoporosis in bullous diseases].
    Cappio F; Colombo MD; Caputo R
    G Ital Dermatol Venereol; 1990 Dec; 125(12):LXI-LXIV. PubMed ID: 2091976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term (3 years) prevention of trabecular postmenopausal bone loss with low-dose intermittent nasal salmon calcitonin.
    Reginster JY; Denis D; Deroisy R; Lecart MP; De Longueville M; Zegels B; Sarlet N; Noirfalisse P; Franchimont P
    J Bone Miner Res; 1994 Jan; 9(1):69-73. PubMed ID: 8154311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of salmon calcitonin nasal spray on bone mass in patients with high turnover osteoporosis.
    Gennari C; Agnusdei D; Camporeale A
    Osteoporos Int; 1993; 3 Suppl 1():208-10. PubMed ID: 8461563
    [No Abstract]   [Full Text] [Related]  

  • 10. Intranasal calcitonin suppresses increased bone resorption during short-term immobilization: a double-blind study of the effects of intranasal calcitonin on biochemical parameters of bone turnover.
    van der Wiel HE; Lips P; Nauta J; Kwakkel G; Hazenberg G; Netelenbos JC; van der Vijgh WJ
    J Bone Miner Res; 1993 Dec; 8(12):1459-65. PubMed ID: 8304047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of corticosteroid osteoporosis. A comparison of calcium, calcitriol, and calcitonin.
    Sambrook P; Birmingham J; Kelly P; Kempler S; Nguyen T; Pocock N; Eisman J
    N Engl J Med; 1993 Jun; 328(24):1747-52. PubMed ID: 7684512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of corticosteroid-induced osteoporosis with salmon calcitonin in sarcoid patients.
    Montemurro L; Schiraldi G; Fraioli P; Tosi G; Riboldi A; Rizzato G
    Calcif Tissue Int; 1991 Aug; 49(2):71-6. PubMed ID: 1913297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1-Year controlled randomised trial of prevention of early postmenopausal bone loss by intranasal calcitonin.
    Reginster JY; Denis D; Albert A; Deroisy R; Lecart MP; Fontaine MA; Lambelin P; Franchimont P
    Lancet; 1987 Dec; 2(8574):1481-3. PubMed ID: 2892047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salmon calcitonin (Miacalcic) nasal spray in prevention and treatment of osteoporosis.
    Gennari C
    Clin Rheumatol; 1989 Jun; 8 Suppl 2():61-5. PubMed ID: 2667872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind, placebo-controlled, dose-finding trial of intermittent nasal salmon calcitonin for prevention of postmenopausal lumbar spine bone loss.
    Reginster JY; Deroisy R; Lecart MP; Sarlet N; Zegels B; Jupsin I; de Longueville M; Franchimont P
    Am J Med; 1995 May; 98(5):452-8. PubMed ID: 7733123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skeletal effects of cyclic recombinant human growth hormone and salmon calcitonin in osteopenic postmenopausal women.
    Holloway L; Kohlmeier L; Kent K; Marcus R
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1111-7. PubMed ID: 9100582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of alendronate and intranasal calcitonin for treatment of osteoporosis in postmenopausal women.
    Downs RW; Bell NH; Ettinger MP; Walsh BW; Favus MJ; Mako B; Wang L; Smith ME; Gormley GJ; Melton ME
    J Clin Endocrinol Metab; 2000 May; 85(5):1783-8. PubMed ID: 10843152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nasal calcitonin.
    Silverman SL
    Endocrine; 1997 Apr; 6(2):199-202. PubMed ID: 9225136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone turnover in postmenopausal osteoporosis. Effect of calcitonin treatment.
    Civitelli R; Gonnelli S; Zacchei F; Bigazzi S; Vattimo A; Avioli LV; Gennari C
    J Clin Invest; 1988 Oct; 82(4):1268-74. PubMed ID: 3262626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Calcitonin nasal spray for Paget's disease of the bone].
    Luboshitzky R; Bar-Shalom R
    Harefuah; 1995 Mar; 128(6):358-62, 399. PubMed ID: 7750816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.